Autodisplay: Development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains

Infection and Immunity

Volumn 71, Issue 4, 2003, Pages 1944-1952

  Kramer, Uwe ^a   Rizos, Konstantin ^b,d   Apfel, Heiko ^b   Autenrieth, Ingo B ^a   Lattemann, Claus T ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b CREATOGEN AG   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AIDA1 FUSION PROTEIN; EPITOPE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 60; HYBRID PROTEIN; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; PROTEIN AIDA 1; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENETIC STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SALMONELLA; SALMONELLA ENTERICA; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; VACCINATION; YERSINIA ENTEROCOLITICA;

EID: 0344837302     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.4.1944-1952.2003     Document Type: Article

References (46)

1. Benz, I., and M. A. Schmidt. 1989. Cloning and expression of an adhesin (AIDA-I) involved in diffuse adherence of enteropathogenic Escherichia coli. Infect. Immun. 57:1506-1511.
2. Charbit, A., A. Molla, W. Saurin, and M. Hofnung. 1988. Versatility of a vector for expressing foreign polypeptides at the surface of gram-negative bacteria. Gene 70:181-189.
3. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10:888-892.
4. Choi, A. H., M. Basu, M. M. McNeal, J. Flint, J. L. VanCott, J. D. Clements, and R. L. Ward. 2000. Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J. Virol. 74:11574-11580.
5. Cornelis, P. 2000. Expressing genes in different Escherichia coli compartments. Curr. Opin. Biotechnol. 11:450-454.
6. Curtiss, R., III, K. Nakayama, and S. M. Kelly. 1989. Recombinant avirulent Salmonella vaccine strains with stable maintenance and high-level expression of cloned genes in vivo. Immunol. Investig. 18:583-596.
7. De Almeida, M. E. S., S. M. Newton, and L. C. Ferreira. 1999. Antibody responses against flagellin in mice orally immunized with attenuated Salmonella vaccine strains. Arch. Microbiol. 172:102-108.
8. Dunstan, S. J., C. P. Simmons, and R. A. Strugnell. 1998. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect. Immun. 66:732-740.
9. Ermak, T. H., P. J. Giannasca, R. Nichols, G. A. Myers, J. Nedrud, R. Weltzin, C. K. Lee, H. Kleanthous, and T. P. Monath. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188:2277-2288.
10. Galen, J. E., and M. M. Levine. 2001. Can a "flawless" live vector vaccine strain be engineered? Trends Microbiol. 9:372-376.
11. Galen, J. E., J. Nair, J. Y. Wang, S. S. Wasserman, M. K. Tanner, M. B. Sztein, and M. M. Levine. 1999. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect. Immun. 67:6424-6433.
12. Gentschev, I., G. Dietrich, S. Spreng, A. Kolb-Maurer, J. Daniels, J. Hess, S. H. Kaufmann, and W. Goebel. 2000. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes. J. Biotechnol. 83:19-26.
13. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450.
14. Hayes, L. J., J. W. Conlan, J. S. Everson, M. E. Ward, and I. N. Clarke. 1991. Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium: their application as potential immunogens. J. Gen. Microbiol. 137(Pt. 7):1557-1564.
15. Hess, J., I. Gentschev, D. Miko, M. Welzel, C. Ladel, W. Goebel, and S. H. Kaufmann. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93:1458-1463.
16. + TCR-ab cells and IFN-γ in bacterial clearance independent of intracellular location. J. Immunol. 156:3321-3326.
17. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA 92:2904-2908.
18. Igwe, E. I., H. Rüssmann, A. Roggenkamp, A. Noll, I. B. Autenrieth, and J. Heesemann. 1999. Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect. Immun. 67:5500-5507.
19. Janssen, R., and J. Tommassen. 1994. PhoE protein as a carrier for foreign epitopes. Int. Rev. Immunol. 11:113-121.
20. Janssen, R., M. Wauben, R. van der Zee, M. de Gast, and J. Tommassen. 1994. Influence of amino acids of a carrier protein flanking an inserted T-cell determinant on T-cell stimulation. Int. Immunol. 6:1187-1193.
21. Jose, J., F. Jahnig, and T. F. Meyer. 1995. Common structural features of IgA1 protease-like outer membrane protein autotransporters. Mol. Microbiol. 18:378-380.
22. Jose, J., J. Krämer, T. Klauser, J. Pohlner, and T. F. Meyer. 1996. Absence of periplasmic DsbA oxidoreductase facilitates export of cysteine-containing passenger proteins to the Escherichia coli cell surface via the IgA beta autotransporter pathway. Gene 178:107-110.
23. Klauser, T., J. Pohlner, and T. F. Meyer. 1990. Extracellular transport of cholera toxin B subunit using Neisseria IgA protease beta-domain: conformation-dependent outer membrane translocation. EMBO J. 9:1991-1999.
24. Konieczny, M. P., M. Suhr, A. Noll, I. B. Autenrieth, and M. Alexander Schmidt. 2000. Cell surface presentation of recombinant (poly-) peptides including functional T-cell epitopes by the AIDA autotransporter system. FEMS Immunol. Med. Microbiol. 27:321-332.
25. Lattemann, C. T., J. Maurer, E. Gerland, and T. F. Meyer. 2000. Autodisplay: functional display of active β-lactamase on the surface of Escherichia coli by the AIDA-I autotransporter. J. Bacteriol. 182:3726-3733.
26. Lattemann, C. T., Z. X. Yan, A. Matzen, T. F. Meyer, and H. Apfel. 1999. Immunogenicity of the extracellular copper/zinc superoxide dismutase of the filarial parasite Acanthocheilonema viteae delivered by a two-phase vaccine strain of Salmonella typhimurium. Parasite Immunol. 21:219-224.
27. Leclerc, C., A. Charbit, A. Molla, and M. Hofnung. 1989. Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization. Vaccine 7:242-248.
28. Lee, J. S., K. S. Shin, J. G. Pan, and C. J. Kim. 2000. Surface-displayed viral antigens on Salmonella carrier vaccine. Nat. Biotechnol. 18:645-648.
29. - Salmonella vaccines. Microb. Pathog. 13:477-491.
30. Maurer, J., J. Jose, and T. F. Meyer. 1997. Autodisplay: one-component system for efficient surface display and release of soluble recombinant proteins from Escherichia coli. J. Bacteriol. 179:794-804.
31. Maurer, J., J. Jose, and T. F. Meyer. 1999. Characterization of the essential transport function of the AIDA-I autotransporter and evidence supporting structural predictions. J. Bacteriol. 181:7014-7020.
32. McNeal, M. M., J. L. VanCott, A. H. Choi, M. Basu, J. A. Flint, S. C. Stone, J. D. Clements, and R. L. Ward. 2002. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J. Virol. 76:560-568.
33. + gene: application to cholera vaccine development. Gene 107:139-144.
34. Newton, S. M., T. M. Joys, S. A. Anderson, R. C. Kennedy, M. E. Hovi, and B. A. Stocker. 1995. Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Res. Microbiol. 146:203-216.
35. Newton, S. M. C., C. O. Jacob, and B. A. D. Stocker. 1989. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244:70-72.
36. Noll, A., and I. B. Autenrieth. 1996. Yersinia-hsp60-reactive T cells are efficiently stimulated by peptides of 12 and 13 amino acid residues in a MHC class II (I-Ab)-restricted manner. Clin. Exp. Immunol. 105:231-237.
37. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. Findlay, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-362.
38. Pohlner, J., R. Halter, K. Beyreuther, and T. F. Meyer. 1987. Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature 325:458-462.
39. Ruiz-Perez, F., R. Leon-Kempis, A. Santiago-Machuca, G. Ortega-Pierres, E. Barry, M. Levine, and C. Gonzalez-Bonilla. 2002. Expression of the Plasmodium falciparum immunodominant epitope (NANP4) on the surface of Salmonella enterica using the autotransporter MisL. Infect. Immun. 70:3611-3620.
40. Rüssmann, H., E. I. Igwe, J. Sauer, W. D. Hardt, A. Bubert, and G. Geginat. 2001. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J. Immunol. 167:357-365.
41. Rüssmann, H., H. Shams, F. Poblete, Y. Fu, J. E. Galán, and R. O. Donis. 1998. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281:565-568.
42. Shimada, K., Y. Ohnishi, S. Horinouchi, and T. Beppu. 1994. Extracellular transport of pseudoazurin of alcaligenes faecalis in Escherichia coli using the COOH-terminal domain of Serratia marcescens serine protease. J. Biochem. 116:327-334.
43. Tommassen, J., M. Agterberg, R. Janssen, and G. Spierings. 1993. Use of the enterobacterial outer membrane protein PhoE in the development of new vaccines and DNA probes. Zentbl. Bakteriol. 278:396-406.
44. Valentine, P. J., B. P. Devore, and F. Heffron. 1998. Identification of three highly attenuated Salmonella typhimurium mutants that are more immunogenic and protective in mice than a prototypical aroA mutant. Infect. Immun. 66:3378-3383.
45. VanCott, J. L., S. N. Chatfield, M. Roberts, D. M. Hone, E. L. Hohmann, D. W. Pascual, M. Yamamoto, H. Kiyono, and J. R. McGhee. 1998. Regulation of host immune responses by modification of Salmonella virulence genes. Nat. Med. 4:1247-1252.
46. -) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol. 145:2281-2285.